Jean-Yves Blay: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Decision making process in oncology practice: Is the information available and what should it consist of?

Jean Trédaniel, Jean-Yves Blay, François Goldwasser, Bernard Asselain, Serge Koscielny, Cécile de Labareyre, Nives Balogh, Hervé Bismut, Jean-Louis Misset, Michel Marty

Journal:

Critical Reviews in Oncology/Hematology

Year:

2005

Language:

english

File:

PDF, 145 KB

english, 2005

2

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Cesne, Axel Le, Blay, Jean-Yves, Domont, Julien, Tresch-Bruneel, Emmanuelle, Chevreau, Christine, Bertucci, François, Delcambre, Corinne, Saada-Bouzid, Esma, Piperno-Neumann, Sophie, Bay, Jacques-Oliv

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 346 KB

english, 2015

3

Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Diamond, Eli L., Subbiah, Vivek, Lockhart, A. Craig, Blay, Jean-Yves, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena, Martín

Journal:

Year:

2017

Language:

english

File:

PDF, 276 KB

english, 2017

4

Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens

Isabelle Ray-Coquard, Pierre Biron, Thomas Bachelot, Jean-Paul Guastalla, Gilles Catimel, Yacine Merrouche, Jean-Pierre Droz, Franck Chauvin, Jean-Yves Blay

Journal:

Year:

1998

Language:

english

File:

PDF, 82 KB

english, 1998

5

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Jaap Verweij, Paolo G Casali, John Zalcberg, Axel LeCesne, Peter Reichardt, Jean-Yves Blay, Rolf Issels, Allan van Oosterom, Pancras CW Hogendoorn, Martine Van Glabbeke, Rossella Bertulli, Ian Judson

Journal:

Year:

2004

Language:

english

File:

PDF, 216 KB

english, 2004

6

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

David Thomas, Robert Henshaw, Keith Skubitz, Sant Chawla, Arthur Staddon, Jean-Yves Blay, Martine Roudier, Judy Smith, Zhishen Ye, Winnie Sohn, Roger Dansey, Susie Jun

Journal:

The Lancet Oncology

Year:

2010

Language:

english

File:

PDF, 308 KB

english, 2010

7

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

Hyman, David M., Puzanov, Igor, Subbiah, Vivek, Faris, Jason E., Chau, Ian, Blay, Jean-Yves, Wolf, Jürgen, Raje, Noopur S., Diamond, Eli L., Hollebecque, Antoine, Gervais, Radj, Elez-Fernandez, Maria

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 601 KB

english, 2015

8

The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours

Barrios, Carlos H., Blackstein, Martin E., Blay, Jean-Yves, Casali, Paolo G., Chacon, Matias, Gu, Jin, Kang, Yoon-Koo, Nishida, Toshirou, Purkayastha, Das, Woodman, Richard C., Reichardt, Peter

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 444 KB

english, 2015

9

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for res

Coens, Corneel, van der Graaf, Winette T. A., Blay, Jean-Yves, Chawla, Sant P., Judson, Ian, Sanfilippo, Roberta, Manson, Stephanie C., Hodge, Rachel A., Marreaud, Sandrine, Prins, Judith B., Lugowska

Journal:

Year:

2015

Language:

english

File:

PDF, 225 KB

english, 2015

10

Dépistage du cancer en France : 10 ans d’analyse des comportements par les enquêtes EDIFICE

Eisinger, François, Pivot, Xavier, Greillier, Laurent, Couraud, Sébastien, Cortot, Alexis B., Touboul, Chantal, Lhomel, Christine, Blay, Jean-Yves, Morère, Jean-François, Viguier, Jérôme

Journal:

Bulletin du Cancer

Year:

2017

File:

PDF, 1.02 MB

2017

11

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy. An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcom

Lindner, Lars H., Litière, Saskia, Sleijfer, Stefan, Benson, Charlotte, Italiano, Antoine, Kasper, Bernd, Messiou, Christina, Gelderblom, Hans, Wardelmann, Eva, Le Cesne, Axel, Blay, Jean-Yves, Marrea

Journal:

International Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 575 KB

english, 2018

12

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Lebellec, Loïc, Bertucci, François, Tresch-Bruneel, Emmanuelle, Ray-Coquard, Isabelle, Le Cesne, Axel, Bompas, Emmanuelle, Blay, Jean-Yves, Italiano, Antoine, Mir, Olivier, Ryckewaert, Thomas, Toiron,

Journal:

Year:

2018

Language:

english

File:

PDF, 1018 KB

english, 2018

13

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

Tap, William D, Gelderblom, Hans, Palmerini, Emanuela, Desai, Jayesh, Bauer, Sebastian, Blay, Jean-Yves, Alcindor, Thierry, Ganjoo, Kristen, Martín-Broto, Javier, Ryan, Christopher W, Thomas, David M,

Journal:

Lancet (London, England)

Year:

2019

Language:

english

File:

PDF, 460 KB

english, 2019

14

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study

Chawla, Sant, Blay, Jean-Yves, Rutkowski, Piotr, Le Cesne, Axel, Reichardt, Peter, Gelderblom, Hans, Grimer, Robert J, Choy, Edwin, Skubitz, Keith, Seeger, Leanne, Schuetze, Scott M, Henshaw, Robert,

Journal:

The Lancet Oncology

Year:

2019

Language:

english

File:

PDF, 1.01 MB

english, 2019

15

Evolving role of regorafenib for the treatment of advanced cancers

Grothey, Axel, Blay, Jean-Yves, Pavlakis, Nick, Yoshino, Takayuki, Bruix, Jordi

Journal:

Cancer Treatment Reviews

Year:

2020

Language:

english

File:

PDF, 684 KB

english, 2020

16

Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma

Eric Voog, Pierre Biron, Jean-Pierre Martin, Jean-Yves Blay

Journal:

Year:

1999

Language:

english

File:

PDF, 93 KB

english, 1999

17

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma

Jean-Yves Blay, Jean-François Rossi, John Wijdenes, Christine Menetrier-Caux, Stéphane Schemann, Sylvie Négrier, Thierry Philip, Marie Favrot

Journal:

International Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 191 KB

english, 1997

18

International study on low-grade primary central nervous system lymphoma

Kristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, Jean-Yves Blay, Lauren E. Abrey, Peter Martus, Philip M. P. Poortmans, Tamara N. Shenkier, Tracy T. Batchelor, Edward A. Neuwelt, Jeffrey J. R

Journal:

Annals of Neurology

Year:

2006

Language:

english

File:

PDF, 151 KB

english, 2006

19

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer

Christophe Borg, Isabelle Ray-Coquard, Irene Philip, Gilles Clapisson, Nathalie Bendriss-Vermare, Christine Menetrier-Caux, Catherine Sebban, Pierre Biron, Jean-Yves Blay

Journal:

Year:

2004

Language:

english

File:

PDF, 79 KB

english, 2004

20

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

Philippe A. Cassier, Isabelle Ray-Coquard, Marie-Pierre Sunyach, Laurence Lancry, Jean-Paul Guastalla, Céline Ferlay, Frédéric Gomez, Hervé Curé, Alain Lortholary, Line Claude, Jean-Yves Blay, Thomas

Journal:

Year:

2008

Language:

english

File:

PDF, 139 KB

english, 2008

21

The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor

Alessandro Gronchi, Jean-Yves Blay, Jonathan C. Trent

Journal:

Year:

2010

Language:

english

File:

PDF, 202 KB

english, 2010

22

Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors

Jean-Yves Blay, Margaret von Mehren, Martin E. Blackstein

Journal:

Year:

2010

Language:

english

File:

PDF, 175 KB

english, 2010

23

Trends in survival for patients with metastatic soft-tissue sarcoma

Antoine Italiano, Simone Mathoulin-Pelissier, Axel Le Cesne, Philippe Terrier, Sylvie Bonvalot, Françoise Collin, Jean-Jacques Michels, Jean-Yves Blay, Jean-Michel Coindre, Binh Bui

Journal:

Year:

2011

Language:

english

File:

PDF, 187 KB

english, 2011

24

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

Antoine Italiano, Armelle Laurand, Audrey Laroche, Paolo Casali, Roberta Sanfilippo, Axel Le Cesne, Ian Judson, Jean-Yves Blay, Isabelle Ray-Coquard, Binh Bui, Jean-Michel Coindre, Antonio Nieto, Juan

Journal:

Year:

2011

Language:

english

File:

PDF, 522 KB

english, 2011

25

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

Hervé Ghesquières, Céline Ferlay, Catherine Sebban, Catherine Chassagne, Liana Carausu, Thérèse Gargi, Bertrand Favier, Irène Philip, Jean-Yves Blay, Pierre Biron

Journal:

Hematological Oncology

Year:

2008

Language:

english

File:

PDF, 289 KB

english, 2008

26

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response

Angélique Gougelet, Daniel Pissaloux, Anthony Besse, Jennifer Perez, Adeline Duc, Aurélie Dutour, Jean-Yves Blay, Laurent Alberti

Journal:

International Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 921 KB

english, 2011

27

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate

Michele Reni, Andrés J.M Ferreri, Nandita Guha-Thakurta, Jean-Yves Blay, Stefania Dell’Oro, Pierre Biron, Fred H Hochberg

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2001

Language:

english

File:

PDF, 111 KB

english, 2001

28

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Aurore Blesius, Philippe A Cassier, François Bertucci, Jerome Fayette, Isabelle Ray-Coquard, Binh Bui, Antoine Adenis, Maria Rios, Didier Cupissol, David Pérol, Jean-Yves Blay, Axel Le Cesne

Journal:

Year:

2011

Language:

english

File:

PDF, 330 KB

english, 2011

29

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

Olivier Trédan, Isabelle Ray-Coquard, Gisèle Chvetzoff, Paul Rebattu, Agathe Bajard, Sylvie Chabaud, David Pérol, Chadi Saba, Florent Quiblier, Jean-Yves Blay, Thomas Bachelot

Journal:

Year:

2011

Language:

english

File:

PDF, 219 KB

english, 2011

30

Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival

Sana Intidhar Labidi, Christine Ménétrier-Caux, Sylvie Chabaud, Catherine Chassagne, Catherine Sebban, Thérèse Gargi, Pierre Biron, Jean-Yves Blay, Hervé Ghesquières

Journal:

Annals of Hematology

Year:

2010

Language:

english

File:

PDF, 162 KB

english, 2010

31

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors

Robert S. Benjamin, Patrick Schöffski, Jörg Thomas Hartmann, Allan Van Oosterom, Binh Nguyen Bui, Justus Duyster, Scott Schuetze, Jean-Yves Blay, Peter Reichardt, Lee S. Rosen, Keith Skubitz, Sheryl M

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 438 KB

english, 2011

32

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006

Guillaume Galy, Sana Intidhar Labidi-Galy, David Perol, Thomas Bachelot, Isabelle Ray-Coquard, Olivier Tredan, Pierre Biron, Jean-François Latour, Jean-Yves Blay, Jean-Paul Guastalla, Bertrand Favier

Journal:

Breast Cancer Research and Treatment

Year:

2011

Language:

english

File:

PDF, 297 KB

english, 2011

33

Cancer screening in France: subjects’ and physicians’ attitudes

François Eisinger, Jean-Yves Blay, Jean-François Morère, Olivier Rixe, Anne Calazel-Benque, Laurent Cals, Yvan Coscas, Sylvie Dolbeault, Moïse Namer, Daniel Serin, Claire Roussel, Xavier Pivot, on beh

Journal:

Cancer Causes & Control

Year:

2008

Language:

english

File:

PDF, 208 KB

english, 2008

34

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

Nicolas Penel, Jean-Pierre Delord, Marie-Edith Bonneterre, Thomas Bachelot, Isabelle Ray-Coquard, Jean-Yves Blay, Laurent Benjamin Pascal, Cécile Borel, Thomas Filleron, Antoine Adenis, Jacques Bonnet

Journal:

Investigational New Drugs

Year:

2010

Language:

english

File:

PDF, 135 KB

english, 2010

35

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

Jérôme Fayette, Nicolas Penel, Christine Chevreau, Jean-Yves Blay, Didier Cupissol, Antoine Thyss, Cécile Guillemet, Maria Rios, Frédéric Rolland, Pierre Fargeot, Jacques Olivier Bay, Simone Mathoulin

Journal:

Investigational New Drugs

Year:

2009

Language:

english

File:

PDF, 150 KB

english, 2009

36

Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib

Nathalie Lassau, Linda Chami, Serge Koscielny, Mohamed Chebil, Christophe Massard, Baya Benatsou, Sophie Bidault, Angela Cioffi, Jean-Yves Blay, Axel Le Cesne

Journal:

Investigational New Drugs

Year:

2012

Language:

english

File:

PDF, 602 KB

english, 2012

37

Molecular response prediction in gastrointestinal stromal tumors

Philippe A. Cassier, Jean-Yves Blay

Journal:

Targeted Oncology

Year:

2010

Language:

english

File:

PDF, 176 KB

english, 2010

38

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

Philippe A. Cassier, Armelle Dufresne, Samia Arifi, Hiba El Sayadi, Isabelle Ray-Coquard, Pierre-Paul Bringuier, Jean-Yves Scoazec, Laurent Alberti, Jean-Yves Blay

Journal:

Current Gastroenterology Reports

Year:

2008

Language:

english

File:

PDF, 282 KB

english, 2008

39

Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE)

Jean-Yves Blay, Serge Koscielny, Jean Trédaniel, Bernard Asselain, François Goldwasser, Jean-Louis Misset, Cécile de Labareyre, Charles Hagège, Hervé Bismut, Michel Marty

Journal:

Critical Reviews in Oncology/Hematology

Year:

2007

Language:

english

File:

PDF, 145 KB

english, 2007

40

Increasing Coverage Rates for Mammographic Screening in France in Older Women––16 Years of Follow-Up

Francois Eisinger, Francois Beck, Jerome Viguier, Jean-Yves Blay, Yvan Coscas, Claire Roussel, Jean-Francois Morère, Xavier Pivot

Journal:

The Breast Journal

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

41

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

Antoine Italiano, Angela Cioffi, Nicolas Penel, Matteo Giaj Levra, Corinne Delcambre, Elsa Kalbacher, Christine Chevreau, François Bertucci, Nicolas Isambert, Jean-Yves Blay, Binh Bui, Cristina Antone

Journal:

Year:

2012

Language:

english

File:

PDF, 232 KB

english, 2012

42

Incidence of soft tissue sarcoma and beyond : A population-based prospective study in 3 European regions

Giuseppe Mastrangelo, Jean-Michel Coindre, Françoise Ducimetière, Angelo Paolo Dei Tos, Emanuela Fadda, Jean-Yves Blay, Alessandra Buja, Ugo Fedeli, Luca Cegolon, Alvise Frasson, Dominique Ranchère-Vi

Journal:

Year:

2012

Language:

english

File:

PDF, 1.01 MB

english, 2012

43

Desmoplastic small round cell tumors with EWS-WT1 fusion transcript in children and young adults

Pascale Philippe-Chomette, Nabil Kabbara, Nicolas Andre, Gaelle Pierron, Aurore Coulomb, Valérie Laurence, Jean-Yves Blay, Olivier Delattre, Gudrun Schleiermacher, Daniel Orbach

Journal:

Pediatric Blood & Cancer

Year:

2012

Language:

english

File:

PDF, 268 KB

english, 2012

44

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

Axel Le Cesne, Alejandro Yovine, Jean-Yves Blay, Suzette Delaloge, Robert G. Maki, Jean-Louis Misset, Pilar Frontelo, Antonio Nieto, Juhui James Jiao, George D. Demetri

Journal:

Investigational New Drugs

Year:

2012

Language:

english

File:

PDF, 269 KB

english, 2012

45

Tumeur stromale colique asymptomatique révélée par un sarcome de Kaposi classique chez une malade VIH négative

Vincent Baty, Jean-Yves Blay, Véronique Michalet, Bénédicte Prost, Catherine Agard, Dominique Ranchère-Vince, Eric Fontaumard, Isabelle Ray-Coquard

Journal:

Gastroentérologie Clinique et Biologique

Year:

2004

Language:

french

File:

PDF, 146 KB

french, 2004

46

Gastrointestinal stromal tumors (GIST)

Bruno Landi, Olivier Bouche, Jean-Yves Blay

Journal:

Gastroentérologie Clinique et Biologique

Year:

2006

Language:

english

File:

PDF, 76 KB

english, 2006

47

Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases

Serge Evrard, Christine Menetrier-Caux, Cathy Biota, Véronique Neaud, Simone Mathoulin-Pélissier, Jean-Yves Blay, Jean Rosenbaum

Journal:

Gastroentérologie Clinique et Biologique

Year:

2007

File:

PDF, 735 KB

2007

48

Sarcomas With Spindle Cell Morphology

Paola Collini, Poul H.B. Sorensen, Shreyaskumar Patel, Jean-Yves Blay, Rolf D. Issels, Robert G. Maki, Mikael Eriksson, Xavier Garcia del Muro

Journal:

Seminars in Oncology

Year:

2009

Language:

english

File:

PDF, 1.95 MB

english, 2009

49

Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor

Jean-Yves Blay, Margaret von Mehren

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 697 KB

english, 2011

50

The Evolution of a Revolutionary Class: Extending Benefits of Tyrosine Kinase Inhibitors—Introduction

Jean-Yves Blay, George D. Demetri

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 97 KB

english, 2011